REPORT ID 2115

Asia-Pacific Orphan Drugs Market Report 2019

Publish Date
2019
Pages
113
Format
Electronic (PDF)

In this report, the Asia-Pacific Orphan Drugs market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Orphan Drugs for these regions, from   2019 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Orphan Drugs market competition by top manufacturers/players, with Orphan Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novartis AG
    Bristol-Myers Squibb Company
    Celgene Corporation
    F. Hoffmann-La Roche Ltd.
    Pfizer, Inc.
    Sanofi S.A.
    Alexion Pharmaceuticals, Inc.
    Eli Lilly and Company
    Novo Nordisk A/S
    AstraZeneca
    Eisai Co., Ltd.
    Daiichi Sankyo Company Limited
    Bayer AG
    GlaxoSmithKline
    Merck & Co., Inc.
    Johnson & Johnson
    Biogen, Inc.
    Shire
    Amgen, Inc.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Oncology
    Gastrointestinal
    Pulmonary
    Neurology
    Hematology
    Cardio-vascular
    Metabolic disorders
    Endocrinology
    Infectious diseases
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Orphan Drugs for each application, includin
    Hospital Pharmacies
    Speciality Pharmacies
    Retail pharmacies
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Orphan Drugs Market  Report 2019
1 Orphan Drugs Overview
    1.1 Product Overview and Scope of Orphan Drugs
    1.2 Classification of Orphan Drugs by Product Category
        1.2.1 Asia-Pacific Orphan Drugs Market Size (Sales) Comparison by Types ( 2014-2024)
        1.2.2 Asia-Pacific Orphan Drugs Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Oncology
        1.2.4 Gastrointestinal
        1.2.5 Pulmonary
        1.2.6 Neurology
        1.2.7 Hematology
        1.2.8 Cardio-vascular
        1.2.9 Metabolic disorders
        1.2.10 Endocrinology
        1.2.11 Infectious diseases
        1.2.12 Others
    1.3 Asia-Pacific Orphan Drugs Market by Application/End Users
        1.3.1 Asia-Pacific Orphan Drugs Sales (Volume) and Market Share Comparison by Applications ( 2014-2024)
        1.3.2 Hospital Pharmacies
        1.3.3 Speciality Pharmacies
        1.3.4 Retail pharmacies
        1.3.5 Others
    1.4 Asia-Pacific Orphan Drugs Market by Region
        1.4.1 Asia-Pacific Orphan Drugs Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 China Status and Prospect ( 2014-2024)
        1.4.3 Japan Status and Prospect ( 2014-2024)
        1.4.4 South Korea Status and Prospect ( 2014-2024)
        1.4.5 Taiwan Status and Prospect ( 2014-2024)
        1.4.6 India Status and Prospect ( 2014-2024)
        1.4.7 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.8 Australia Status and Prospect ( 2014-2024)
    1.5 Asia-Pacific Market Size (Value and Volume) of Orphan Drugs ( 2014-2024)
        1.5.1 Asia-Pacific Orphan Drugs Sales and Growth Rate ( 2014-2024)
        1.5.2 Asia-Pacific Orphan Drugs Revenue and Growth Rate ( 2014-2024)

2 Asia-Pacific Orphan Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Orphan Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Orphan Drugs Sales Volume and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Asia-Pacific Orphan Drugs Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Asia-Pacific Orphan Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific Orphan Drugs Sales and Market Share by Type ( 2014-2019)
        2.2.2 Asia-Pacific Orphan Drugs Revenue and Market Share by Type ( 2014-2019)
    2.3 Asia-Pacific Orphan Drugs (Volume) by Application
    2.4 Asia-Pacific Orphan Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific Orphan Drugs Sales and Market Share by Region ( 2014-2019)
        2.4.2 Asia-Pacific Orphan Drugs Revenue and Market Share by Region ( 2014-2019)

3 China Orphan Drugs (Volume, Value and Sales Price)
    3.1 China Orphan Drugs Sales and Value ( 2014-2019)
        3.1.1 China Orphan Drugs Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 China Orphan Drugs Revenue and Growth Rate ( 2014-2019)
        3.1.3 China Orphan Drugs Sales Price Trend ( 2014-2019)
    3.2 China Orphan Drugs Sales Volume and Market Share by Type
    3.3 China Orphan Drugs Sales Volume and Market Share by Application

4 Japan Orphan Drugs (Volume, Value and Sales Price)
    4.1 Japan Orphan Drugs Sales and Value ( 2014-2019)
        4.1.1 Japan Orphan Drugs Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Japan Orphan Drugs Revenue and Growth Rate ( 2014-2019)
        4.1.3 Japan Orphan Drugs Sales Price Trend ( 2014-2019)
    4.2 Japan Orphan Drugs Sales Volume and Market Share by Type
    4.3 Japan Orphan Drugs Sales Volume and Market Share by Application

5 South Korea Orphan Drugs (Volume, Value and Sales Price)
    5.1 South Korea Orphan Drugs Sales and Value ( 2014-2019)
        5.1.1 South Korea Orphan Drugs Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 South Korea Orphan Drugs Revenue and Growth Rate ( 2014-2019)
        5.1.3 South Korea Orphan Drugs Sales Price Trend ( 2014-2019)
    5.2 South Korea Orphan Drugs Sales Volume and Market Share by Type
    5.3 South Korea Orphan Drugs Sales Volume and Market Share by Application

6 Taiwan Orphan Drugs (Volume, Value and Sales Price)
    6.1 Taiwan Orphan Drugs Sales and Value ( 2014-2019)
        6.1.1 Taiwan Orphan Drugs Sales Volume and Growth Rate ( 2014-2019)
        6.1.2 Taiwan Orphan Drugs Revenue and Growth Rate ( 2014-2019)
        6.1.3 Taiwan Orphan Drugs Sales Price Trend ( 2014-2019)
    6.2 Taiwan Orphan Drugs Sales Volume and Market Share by Type
    6.3 Taiwan Orphan Drugs Sales Volume and Market Share by Application

7 India Orphan Drugs (Volume, Value and Sales Price)
    7.1 India Orphan Drugs Sales and Value ( 2014-2019)
        7.1.1 India Orphan Drugs Sales Volume and Growth Rate ( 2014-2019)
        7.1.2 India Orphan Drugs Revenue and Growth Rate ( 2014-2019)
        7.1.3 India Orphan Drugs Sales Price Trend ( 2014-2019)
    7.2 India Orphan Drugs Sales Volume and Market Share by Type
    7.3 India Orphan Drugs Sales Volume and Market Share by Application

8 Southeast Asia Orphan Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia Orphan Drugs Sales and Value ( 2014-2019)
        8.1.1 Southeast Asia Orphan Drugs Sales Volume and Growth Rate ( 2014-2019)
        8.1.2 Southeast Asia Orphan Drugs Revenue and Growth Rate ( 2014-2019)
        8.1.3 Southeast Asia Orphan Drugs Sales Price Trend ( 2014-2019)
    8.2 Southeast Asia Orphan Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia Orphan Drugs Sales Volume and Market Share by Application

9 Australia Orphan Drugs (Volume, Value and Sales Price)
    9.1 Australia Orphan Drugs Sales and Value ( 2014-2019)
        9.1.1 Australia Orphan Drugs Sales Volume and Growth Rate ( 2014-2019)
        9.1.2 Australia Orphan Drugs Revenue and Growth Rate ( 2014-2019)
        9.1.3 Australia Orphan Drugs Sales Price Trend ( 2014-2019)
    9.2 Australia Orphan Drugs Sales Volume and Market Share by Type
    9.3 Australia Orphan Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Orphan Drugs Players/Suppliers Profiles and Sales Data
    10.1 Novartis AG
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Orphan Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Novartis AG Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.1.4 Main Business/Business Overview
    10.2 Bristol-Myers Squibb Company
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Orphan Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.2.4 Main Business/Business Overview
    10.3 Celgene Corporation
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Orphan Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Celgene Corporation Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.3.4 Main Business/Business Overview
    10.4 F. Hoffmann-La Roche Ltd.
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Orphan Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.4.4 Main Business/Business Overview
    10.5 Pfizer, Inc.
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Orphan Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Pfizer, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.5.4 Main Business/Business Overview
    10.6 Sanofi S.A.
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Orphan Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Sanofi S.A. Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.6.4 Main Business/Business Overview
    10.7 Alexion Pharmaceuticals, Inc.
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Orphan Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.7.4 Main Business/Business Overview
    10.8 Eli Lilly and Company
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Orphan Drugs Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Eli Lilly and Company Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.8.4 Main Business/Business Overview
    10.9 Novo Nordisk A/S
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Orphan Drugs Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Novo Nordisk A/S Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.9.4 Main Business/Business Overview
    10.10 AstraZeneca
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Orphan Drugs Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 AstraZeneca Orphan Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.10.4 Main Business/Business Overview
    10.11 Eisai Co., Ltd.
    10.12 Daiichi Sankyo Company Limited
    10.13 Bayer AG
    10.14 GlaxoSmithKline
    10.15 Merck & Co., Inc.
    10.16 Johnson & Johnson
    10.17 Biogen, Inc.
    10.18 Shire
    10.19 Amgen, Inc.

11 Orphan Drugs Manufacturing Cost Analysis
    11.1 Orphan Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Orphan Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Orphan Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Orphan Drugs Major Manufacturers  in 2018
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Orphan Drugs Market Forecast ( 2019-2025)
    15.1 Asia-Pacific Orphan Drugs Sales Volume, Revenue and Price Forecast ( 2019-2025)
        15.1.1 Asia-Pacific Orphan Drugs Sales Volume and Growth Rate Forecast ( 2019-2025)
        15.1.2 Asia-Pacific Orphan Drugs Revenue and Growth Rate Forecast ( 2019-2025)
        15.1.3 Asia-Pacific Orphan Drugs Price and Trend Forecast ( 2019-2025)
    15.2 Asia-Pacific Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.1 Asia-Pacific Orphan Drugs Sales Volume and Growth Rate Forecast by Region ( 2019-2025)
        15.2.2 Asia-Pacific Orphan Drugs Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.3 China Orphan Drugs Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.4 Japan Orphan Drugs Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.5 South Korea Orphan Drugs Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.6 Taiwan Orphan Drugs Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.7 India Orphan Drugs Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.8 Southeast Asia Orphan Drugs Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.9 Australia Orphan Drugs Sales, Revenue and Growth Rate Forecast ( 2019-2025)
    15.3 Asia-Pacific Orphan Drugs Sales, Revenue and Price Forecast by Type ( 2019-2025)
        15.3.1 Asia-Pacific Orphan Drugs Sales Forecast by Type ( 2019-2025)
        15.3.2 Asia-Pacific Orphan Drugs Revenue Forecast by Type ( 2019-2025)
        15.3.3 Asia-Pacific Orphan Drugs Price Forecast by Type ( 2019-2025)
    15.4 Asia-Pacific Orphan Drugs Sales Forecast by Application ( 2019-2025)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer